Obese and overweight patients clamouring for Novo Nordisk’s weight-loss and diabetes drugs have helped the Danish drugmaker grow into Europe’s largest company. Now, it wants to go a step further and stop people gaining weight in the first place.
肥胖和超重患者对诺和诺德(Novo Nordisk)减肥和糖尿病药物的强烈需求，帮助这家丹麦制药商成长为欧洲最大的公司。现在，它想更进一步，从一开始就阻止人们发胖。
您已阅读3%（329字），剩余97%（10313字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。